Lin, Anya Maan-Yuh

Current Positions

Dean, College of Pharmaceutical Sciences, NYCU 2022/08~
Professor, Faculty of Pharmacy, NYCU 2016/08~
Adjunct Professor, Institute of Biopharmaceutical Sciences, NYCU 2008/08~
Adjunct Professor, Institute of Pharmacology, NYCU 2008/08~
Adjunct Professor, Institute of Physiology, NYCU 2008/08~
Adjunct Research Fellow, Department of Medical Research, TVGH 2005/04~
President, The Society of Taiwan Women in Sciences and Technology 2019/12~


TEL:02-28267000 #67381
Office:Biomedical Building 2F, 209 Room


Ph.D., Neuroscience/Pharmacology, University of Colorado Health Sciences Center, U.S.A
M.Sc., Pharmacology,National Taiwan University, Taiwan
B.Sc., Pharmacy, National Taiwan University, Taiwan

Research Interest

CNS Neuropharmacology, Translational research

Prior Positions

Director, Department of Pharmacy, NYCU 2016/08~2022/07
Director, Institute of Pharmacology, NYCU 2008/08~2014/07
Associate Research Fellow, Department of Medical Research, TVGH 1996~2005
Postdoctoral Fellow, Institute of Biomedical Sciences, Academia Sinica 1993/10~1996/10
Postdoctoral Fellow, National Institutes of Health, USA 1992/08~1993/09

  1. Oxidative stress in CNS degenerative diseases and during Senescence: Free radical is a side-product of electron-transfer redox process that contains extremely reactive unpaired electron. It is suggested that free radicals regulate the cellular functions and/or neuroprotection or even cell death in biological systems. Indeed, the nigrostriatal system, which controls muscle tone and regulates the initiation of movement, was found deteriorated in Parkinson’s patients and the elderly. I focus on the neurodegeneration in CNS.
  2. Chemotherapy-induced peripheral neuropathy: Arsenic trioxide has been used for APL with some side effects, including peripheral neuropathy. Therefore, the effect of arsenic on the cell death in the dorsal root ganglia is under investigation
  3. Neuroprotective strategy: To prevent neurodegeneration, several strategies have been proposed and investigated, including carboxyfullerene (a nanoparticle), Green tea extract and melatonin. In addition, translational studies will be focused on target cancer therapies which may inhibit activated signaling transductions during neurodegeneration, such as hemorrhagic stroke. In our lab, non-clinical studies of target therapies or herbal extracts will be tested on the animal models.

Former Dean

Dr. Kang, Jaw-Jou


Ph.D. in Chemistry, UCSD|1983-1989
BS in Pharmacy, NTU|1975-1979

Professional Experiences

Present Dean, College of Pharmaceutical Sciences2016/08

Present Professor, Faculty of pharmacy2016/08

Present Professor, Institute of Toxicology, National Taiwan University1998/08

present President, Toxicology Society of Taiwan 2014

Director General, Office of Food Safety, Executive Yuan 2015/02~2016/09

Director-General, Food and Drug Administration, Department of Health, Executive Yuan. 2011/08~2013/07

Director, Drug Research Center, College of Medicine, NTU 2007/08~2011/07

Leader, Toxicologic section, Drug Research Center, College of Medicine, NTU 2001/08~2007/07

Associate Professor, Institute of Toxicology, NTU 1991/08~1998/07

Post Doctoral Fellow, Boston Biomedical Research Institute 1989/05~1991/07